<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11481">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01762306</url>
  </required_header>
  <id_info>
    <org_study_id>SIOGMVA001</org_study_id>
    <nct_id>NCT01762306</nct_id>
  </id_info>
  <brief_title>Efficacy of Diclofenac on Pain During Endometrial Sampling</brief_title>
  <official_title>Efficacy for Acute Pain Alleviation of 50 mg Diclofenac 1 Hour Prior to Endometrial Sampling in Cases of Abnormal Uterine Bleeding</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <authority>Thailand: Ethical Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Abnormal uterine bleeding is common in Thai women. Traditionally, because of a larger number
      of patients, the diagnosis of its cause is performed via fractional curettage under local
      anesthesia such as paracervical nerve block or intravenous meperidine.

      Pain is one of a common adverse effect of this procedure and this topic should be concerned
      by a responsible doctor.

      NSAIDs, Diclofenac Potassium in this study, is known as a drug which is effective for pain
      control and is as effective as coxib in acute pain management. Because of its cost, easy
      accessible and easy administration, Diclofenac Potassium was selected to be used in this
      study. Its onset of action is about 1 hour and only one dose of this drug do not cause any
      serious side effects.

      The hypothesis of this study is that &quot;Diclofenac Potassium has an additional effectiveness
      for acute pain control in patients undergoing fractional curettage under paracervical nerve
      block due to abnormal uterine bleeding&quot; Double blind randomised controlled trial was
      performed in this study with 45 patients included in each group.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">June 2013</completion_date>
  <primary_completion_date type="Anticipated">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Effectiveness of Diclofenac Potassium for additional acute pain control in patient undergoing fractional curettage under paracervical block due to abnormal uterine bleeding</measure>
    <time_frame>1 Year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Effectiveness of oral 50 mg Diclofenac Potassium was measured by pain score using visual dialogue scale during operation and 30, 60, 90 and 120 minutes after procedure.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Abnormal Uterine Bleeding Unrelated to Menstrual Cycle</condition>
  <arm_group>
    <arm_group_label>Diclofenac Potassium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diclofenac Potassium 50 mg PO 1 hour prior to fractional curettage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Folic Acid</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Folic acid 5 mg PO 1 hour prior to fractional curettage</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac Potassium</intervention_name>
    <arm_group_label>Diclofenac Potassium</arm_group_label>
    <other_name>Cataflam</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Folic Acid</intervention_name>
    <arm_group_label>Folic Acid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Thai women at the age over 35 years old

          -  Presenting with abnormal uterine bleeding and have a plan of performing fractional
             curettage

        Exclusion Criteria:

          -  uterine anomalies

          -  pregnancy

          -  Pelvic inflammatory disease

          -  Uncontrolled medical conditions

          -  Known cases of gynecological diseases such as gynecological malignancy, abnormal pap
             smear

          -  NSAIDs allergy

          -  contraindicate to NSAIDs use
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Korakot Sirimai, Dr.</last_name>
    <phone>(66)81-6140655</phone>
    <email>ksirimai@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Medicine Siriraj Hospital Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Korakot Sirimai, Dr.</last_name>
      <phone>(66)81-6140655</phone>
      <email>ksirimai@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Korakot Sirimai, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tripop Lertbunnaphong, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>Poomtavorn Y, Phupong V. Prospective randomized, double-blinded, placebo-controlled trial of preoperative rofecoxib for pain relief in uterine curettage. Arch Gynecol Obstet. 2005 Dec;273(2):115-8. Epub 2005 Jul 27.</citation>
    <PMID>16047182</PMID>
  </reference>
  <reference>
    <citation>Manyou B, Phupong V. Prospective randomized, double-blinded, placebo-controlled trial of preoperative etoricoxib for pain relief in uterine fractional curettage under paracervical block. Eur J Obstet Gynecol Reprod Biol. 2008 Sep;140(1):90-4. doi: 10.1016/j.ejogrb.2008.02.017. Epub 2008 Apr 8. PubMed PMID: 18396369.</citation>
    <PMID>18396369</PMID>
  </reference>
  <reference>
    <citation>Macintyre PE, Walker S, Power I, Schug SA. Acute pain management: scientific evidence revisited. Br J Anaesth. 2006 Jan;96(1):1-4.</citation>
    <PMID>16357114</PMID>
  </reference>
  <reference>
    <citation>Buppasiri P, Tangmanowutikul S, Yoosuk W. Randomized controlled trial of mefenamic acid vs paracervical block for relief of pain for outpatient uterine curettage. J Med Assoc Thai. 2005 Jul;88(7):881-5.</citation>
    <PMID>16241013</PMID>
  </reference>
  <reference>
    <citation>Moore RA, Derry S, McQuay HJ, Wiffen PJ. Single dose oral analgesics for acute postoperative pain in adults. Cochrane Database Syst Rev. 2011 Sep 7;(9):CD008659. doi: 10.1002/14651858.CD008659.pub2. Review.</citation>
    <PMID>21901726</PMID>
  </reference>
  <reference>
    <citation>Derry P, Derry S, Moore RA, McQuay HJ. Single dose oral diclofenac for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004768. doi: 10.1002/14651858.CD004768.pub2. Review.</citation>
    <PMID>19370609</PMID>
  </reference>
  <reference>
    <citation>Boonyarangkul A, Leksakulchai O. Comparison of level of pain between using manual vacuum aspiration and sharp curettage in management of abnormal uterine bleeding. J Med Assoc Thai. 2011 Dec;94 Suppl 7:S57-61.</citation>
    <PMID>22619908</PMID>
  </reference>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>January 4, 2013</lastchanged_date>
  <firstreceived_date>December 11, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Metrorrhagia</mesh_term>
    <mesh_term>Uterine Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
